You are here: Industry Insights > Bladder cancer

News List

CicloMed Expands Fosciclopirox Bladder Cancer Trial americanpharmaceuticalreview
December 09, 2019
CicloMed announced the expansion of its fosciclopirox clinical development program. The fosciclopirox first-in-human Phase 1 trial has been expanded to include patients with ...
The First Bladder Cancer Targeted Therapy Filed the Import Drug Clinical Trial Applications to Start the Road of Marketing in China PharmaSources/Xiaoyaowan
December 04, 2019
According to the CDE website, the Erdafitinib Tablets developed by Janssen under J & J has recently been filed the import drug clinical trial applications in China ...
Sesen Bio Reports Positive, Preliminary Data Update from Trial for Bladder Cancer americanpharmaceuticalreview
August 12, 2019
Sesen Bio reported updated, preliminary primary and secondary endpoint data from the Company’s Phase 3 VISTA trial further supporting the strong benefit-risk profile of Vicinium for the potential treatment of ...
BMS and Infinity trial immunotherapy combo in bladder cancer pharmaphorum
December 14, 2018
Bristol-Myers Squibb has broadened a collaboration with Infinity Pharmaceuticals as it seeks to find combinations that boost the potency of its cancer immunotherapy, Opdivo.
GeneCentric Therapeutics Enters Bladder Cancer Research Collaboration with University of North Carolina pharmafocusasia
December 11, 2018
GeneCentric Therapeutics, Inc. today announced that it has entered into a research collaboration with the University of North Carolina at Chapel Hill (UNC) to assess patient response to....
Final NICE nod for Keytruda in bladder cancer pharmatimes
July 12, 2018
MSD’s Keytruda has become the only immunotherapy to be funded by the NHS for the treatment of bladder cancer, following a final green light from cost regulators.
NICE backs Roche’s Tecentriq for pre-treated bladder cancer pharmatimes
July 12, 2018
Roche’s Tecentriq will be routinely available on the NHS in England and Wales to patients with advanced, pre-treated bladder cancer, following a nod from cost-regulators.
One step closer to personalized treatments for bladder cancer fiercebiotech
July 09, 2018
Over the past few years, there has been a growing movement to classify bladder cancer according to gene expression patterns.
Simultaneous chemo and immunotherapy is effective in metastatic bladder cancer europeanpharmaceuticalreview
April 13, 2018
Researchers have discovered that giving metastatic bladder cancer patients simultaneous chemotherapy and immunotherapy is safe and that patients whose tumours have certain genetic mutations…
New way found to deliver nano-chemo drugs for the treatment of bladder cancer europeanpharmaceuticalreview
October 16, 2017
Researchers have developed a way to successfully deliver nano-sized, platinum-based chemotherapy drugs to treat a form of bladder cancer…

Previous page 1 2 3 4 5 Next page